| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 475,514 | 608,982 | 118,747 | 15,353 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 475,514 | 608,982 | 118,747 | 15,353 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,870 | 8,418 | 7,837 | 6,725 | | Non Recurring |
-
|
-
|
-
| 11,896 | | Others | 344 | 251 | 258 | 909,759 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 457,206 | 600,313 | 110,652 | (913,027) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 267 | | Earnings Before Interest And Taxes | 464,300 | 600,313 | 110,652 | (914,258) | | Interest Expense | 2,026 | 2,310 | 2,758 | 4,194 | | Income Before Tax | 462,274 | 598,003 | 107,894 | (918,452) | | Income Tax Expense | 5 | 5 | 142 |
-
| | Minority Interest |
-
| (2,014) |
-
| (1,498) | | | | Net Income From Continuing Ops | 461,543 | 595,984 | 107,752 | (918,452) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 464,283 | 595,984 | 107,752 | (918,452) | | Preferred Stock And Other Adjustments |
-
| 944 | (944) |
-
| | | Net Income Applicable To Common Shares | $461,543 | $596,928 | $106,808 | ($918,452) |
|
0.51% Nasdaq 
Income Statement
